| Patient | Marcus Aurelius |
|---|---|
| Date of birth | 1973-04-25 |
| Identifiers | MRN HR-AC004-SYN; SSN (made up) 000-04-1213 |
| Document date | 2026-05-12 |
| Author | Octavia Ashworth-Nnamdi, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
The patient attends this visit for new patient visit for chronic epigastric and lower chest pain after meals, poor appetite and poor sleep: cardiac assessment first, review of an opium-containing remedy, and gastroenterology referral for endoscopy. [S]
Hemoglobin: 14.6 g/dL; MCV: 90 fL; White cell count: 6.2 10*3/uL; Platelets: 238 10*3/uL; Sodium: 139 mmol/L; Potassium: 4.3 mmol/L; Urea nitrogen: 14 mg/dL; Creatinine: 0.95 mg/dL; eGFR: 96 mL/min/1.73 m²; Glucose: 92 mg/dL; ALT: 22 U/L; AST: 24 U/L; Alkaline phosphatase: 72 U/L; Total bilirubin: 0.6 mg/dL; Albumin: 4.1 g/dL; Lipase: 32 U/L; Hemoglobin A1c: 5.4%; Total cholesterol: 205 mg/dL (high); HDL cholesterol: 48 mg/dL; Triglycerides: 120 mg/dL; LDL cholesterol (calculated): 133 mg/dL (high); Lipoprotein(a): 38 nmol/L; PHQ-9: 8; GAD-7: 6; AUDIT-C: 3. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-05-12 | Body height | 172 | cm | S |
| 2026-05-12 | Body weight | 63 | kg | S |
| 2026-05-12 | Body mass index (BMI) [Ratio] | 21.3 | kg/m2 | S |
| 2026-05-12 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-05-12 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-05-12 | Heart rate | 76 | /min | S |
| 2026-05-12 | Respiratory rate | 14 | /min | S |
| 2026-05-12 | Body temperature | 36.6 | Cel | S |
| 2026-05-12 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-05-12 | Hemoglobin [Mass/volume] in Blood | 14.6 | g/dL | 13.2-17.1 g/dL | Normal | S |
| 2026-05-12 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 90 | fL | 80-100 fL | Normal | S |
| 2026-05-12 | Leukocytes [#/volume] in Blood by Automated count | 6.2 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 2026-05-12 | Platelets [#/volume] in Blood by Automated count | 238 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-05-12 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-05-12 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-05-12 | Urea nitrogen [Mass/volume] in Serum or Plasma | 14 | mg/dL | 7-20 mg/dL | Normal | S |
| 2026-05-12 | Creatinine [Mass/volume] in Serum or Plasma | 0.95 | mg/dL | 0.7-1.3 mg/dL | Normal | S |
| 2026-05-12 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 96 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-05-12 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 70-139 mg/dL | Normal | S |
| 2026-05-12 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 22 | U/L | 7-55 U/L | Normal | S |
| 2026-05-12 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 | U/L | 8-48 U/L | Normal | S |
| 2026-05-12 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 72 | U/L | 40-129 U/L | Normal | S |
| 2026-05-12 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.6 | mg/dL | 0.1-1.2 mg/dL | Normal | S |
| 2026-05-12 | Albumin [Mass/volume] in Serum or Plasma | 4.1 | g/dL | 3.5-5 g/dL | Normal | S |
| 2026-05-12 | Lipase [Enzymatic activity/volume] in Serum or Plasma | 32 | U/L | 13-60 U/L | Normal | S |
| 2026-05-12 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.4 | % | Below 5.7% is normal; 5.7 to 6.4% prediabetes | Normal | S |
| 2026-05-12 | Cholesterol [Mass/volume] in Serum or Plasma | 205 | mg/dL | <=199 mg/dL | High | S |
| 2026-05-12 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 48 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-05-12 | Triglyceride [Mass/volume] in Serum or Plasma | 120 | mg/dL | <=149 mg/dL | Normal | S |
| 2026-05-12 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 133 | mg/dL | <=129 mg/dL | High | S |
| 2026-05-12 | Lipoprotein a [Moles/volume] in Serum or Plasma | 38 | nmol/L | 125 nmol/L or more adds to cardiovascular risk | Normal | S |
| 2026-05-12 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 8 | {score} | S | ||
| 2026-05-12 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 6 | {score} | S | ||
| 2026-05-12 | Total score [AUDIT-C] | 3 | {score} | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Opium-containing compounded herbal paste (an electuary of honey, many herbs and poppy, from an overseas supplier; not prescribed and not regulated, so its morphine content is unknown), about a pea-sized amount (roughly 0.5 g) by mouth at bedtime most nights for about six years, and now and then in the morning before a long day | About 0.5 g at bedtime most nights; occasionally a second amount in the morning | Oral route | 2020-05-01 to 2026-06-06 | completed | S |
| Calcium carbonate 500 mg chewable tablet, one or two tablets as needed for heartburn, no more than six a day, until the endoscopy | One or two tablets as needed, at least four hours apart; no more than six a day | Oral route | 2026-05-12 to 2026-05-19 | completed | S |
| Polyethylene glycol 3350 powder, 17 g dissolved in a glass of water by mouth once daily as needed for constipation | 17 g once daily as needed | Oral route | 2026-05-12 | active | S |
| Naloxone 4 mg nasal spray, one spray into one nostril for suspected opioid overdose, repeated in 2 to 3 minutes in the other nostril if there is no response; call 911 | One spray for suspected overdose; repeat every 2 to 3 minutes if needed | Nasal route | 2026-05-12 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Burning and pressing pain in the upper abdomen and lower chest after meals, for more than a year and worse over three months, with poor appetite, waking at night with pain and a sour taste, and a 3 kg weight loss; not brought on by exertion; normal ECG; cardiac and peptic causes to be excluded | active | confirmed | R10.13 | S — Synthetic presenting concern at the index visit, superseded by the diagnosis at endoscopy; its pattern echoes the stomach and chest complaints and the pain with food that Dio describes (D). |
| Daily use of an unregulated opium-containing herbal remedy for about six years, for stomach pain and sleep; opioid use disorder criteria not met (one DSM-5-TR criterion, restlessness and poor sleep when he stopped it); expected physiological dependence; constipation and possibly slowed gastric emptying from the opioid | active | confirmed | F11.90 | S — Synthetic modern finding anchored to the theriac he took (D); no opioid use disorder or addiction is attributed to him (the claim is disputed, R). |
| Chronic insomnia disorder for more than a year, with waking from night pain and trouble returning to sleep; Insomnia Severity Index 17 (moderate) | active | confirmed | G47.00 | S — Synthetic modern finding anchored to Galen's account of his sleeplessness without the poppy juice (D, possible). |
| Sustained strain of command: leads a large organization through a long field assignment far from home, with long days and little rest | active | confirmed | Z56.6 | S — Synthetic work strain anchored to his documented years on campaign (D). |
| Constipation from the opioid in his remedy: hard stools every two or three days | active | confirmed | K59.03 | S — Synthetic finding at intake. |